Citation Information :
Rawat V, Devi R, Bajpai A, Kumari R, Shalini S, Kumar A, Dubey G. Effect of Biochemical Changes on Female Infertility, Especially “Leptin and Adiponectin” in Eastern Uttar Pradesh. Int J Infertil Fetal Med 2023; 14 (2):80-84.
Background: Infertility is one of women's most serious clinical problems during their reproductive lives. However, a high body mass index (BMI) and obesity are linked with unhealthy eating patterns and a sedentary lifestyle and have contributed to infertility. Obesity, on the other hand, has been linked to a high rate of infertility over the last 10 years. Additionally, low levels of sex hormones follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, estrogen, progesterone, and testosterone play a significant role in causing infertility, which has a significant impact on the reproductive system. Adipokines are produced by adipose tissue, and adipocytes, including adiponectin and leptin, affect the reproductive organs. Therefore, to comprehend infertility more deeply, it is crucial to assess adipokines and sex hormones. So, the current study involved evaluating the effectiveness and level of adiponectin and leptin in infertility and fertile women of the same reproductive age, along with other hormones like insulin, insulin resistance, FSH, LH, testosterone, and prolactin.
Materials and methods: This study took 56 fertile women to act as a control in their reproductive years as controls and 100 women who have experienced infertility. Cases considerably outperformed controls regarding —BMI, waist-to-hip (W/H) ratio, insulin, and insulin resistance.
Results: Follicle-stimulating hormone (FSH), LH, prolactin, and testosterone levels in cases were higher than in controls. But though adiponectin levels were lower in patients than in controls, leptin levels were higher.
Conclusion: Given that adipokines are regulated by sex hormones, they likely contribute to infertility.
Speroff L, Fritz MA. Anovulation and polycystic ovary, clinical gynecology endocrinology and infertility. Philadelphia PA: Lippincott Williams and Wilkins 2005;465–498.
Chen X, Jia X, Qiao J, et al. Adipokines in reproductive function: a link between obesity and polycystic ovary syndrome. J Mol Endocrinol 2013;50(2):R21–R37. DOI: 10.1530/JME-12-0247
Ferritin S, Sathiyanarayanan S, Umamaheswari R, et al. A study on significant biochemical changes in the serum of infertile women. Med Biol 2014;2(2):95–115.
Pang SC. Use of follicle-stimulating hormone for the treatment of female infertilitycurrent concepts–. Women's Health 2005;1(1):87–95. DOI: 10.2217/17455057.1.1.87
Kallak TK, Hellgren CSkalkidou A, et al. Maternal and female fetal testosterone levels are associated with maternal age and gestational weight gain. Eur J Endocrinol 2017;177(4):379–388. DOI: 10.1530/EJE-17-0207
Svendsen PF, Christiansen M, Hedley PL, et al. Adipose expression of adipocytokines in women with polycystic ovary syndrome. Fertil Steril 2012;98(1):235–241. DOI: 10.1016/j.fertnstert.2012.03.056
Mitchell M, Armstrong DT, Robker RL, et al. Adipokines: implications for female fertility and obesity. Reproduction 2005;130(5):583–597. DOI: 10.1530/rep.1.00521
Budak E, Fernández Sánchez M, Bellver J, et al. Interaction of hormones, leptin, ghrelin, adiponectin, resistin, and pyy3 with reproductive system. Fertil Steril 2006;85(6):1563–1581. DOI: 10.1016/j.fertnstert.2005.09.065
Spritzer PM, Lecke SB, Satler F, et al. Adipose tissue dysfunction, adipokines, and low grade chronic inflammation in polycystic ovary syndrome. Reproduction 2015;149(5):R219–R227. DOI: 10.1530/REP-14-0435
Panidis D, Farmakiotis D, Rousso D, et al. Plasmas visfatin levels in normal weight women with polycystic ovary syndrome. Eur J Intern Med 2008;19(6):406–412. DOI: 10.1016/j.ejim.2007.05.014
Zeger-Hochschild F, Adamson GD, de Mouzon J, et al. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary on ART terminology, 2009. Hum Reprod 2009;24(11):2683–2687. DOI: 10.1093/humrep/dep343
Yin J, Li M, Wang Y, et al. Insulin resistance determined by Homeostasis Model Assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers. Diabetol Metab Syndr 2013;5(1):71. DOI: 10.1186/1758-5996-5-71
Mahmoud MI, Habeeb F, Kasim K. Reproductive and biochemical changes in obese and non obese polycystic ovary syndrome women. Alexandria J Med 2015;51(1):5–9. DOI: 10.1016/j.ajme.2014.03.002
Okamoto M, Endo M, Ikeda M, et al. Hypoadiponectinemia in lean lactating women: prolactin inhibits adiponectin secretion from human adipocytes. Endocr J 2006;53(4):555–562. DOI: 10.1507/endocrj.K06-026
Ramanand SJ, Ramanand JB, Ghongane BB, et al. Correlation between serum adiponectin and clinical characteristics, biochemical parameters in Indian women with polycystic ovary syndrome. Indian J Endocrinol Metab 2014;18(2):221–225. DOI: 10.4103/2230-8210.129116
Dağ ZÖ, Dilbaz B. Impact of obesity on infertility in women. J Turk Ger Gynecol Assoc 2015;16(2):111–117. DOI: 10.5152/jtgga.2015.15232
Kesmodel US (2012). Fertility and Obesity. In: Ovesen P, Møller Jensen D. (eds) Maternal Obesity and Pregnancy. Springer, Berlin, Heidelberg. DOI: 10.1007/978-3-642-25023-1_2
Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83(8):2694–2698. DOI: 10.1210/jcem.83.8.5054
Lecke SB, Mattei F, Morsch DM, et al. Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome. Fertil Steril 2011;95(6):2044–2049. DOI: 10.1016/j.fertnstert2011.02.041
Farshchian F, Hedayati M, Amirrasouli H, et al. Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome. Int J Endocrinol Metab 2014;12(3):e15503. DOI: 10.5812/ijem.15503
Margetic S, Gazzola C, Pegg GG, et al. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002;26(11):1407–1433. DOI: 10.1038/sj.ijo.0802142
Miller KK, Parulekar MS, Schoenfeld E, et al. Decreased leptin level in normal weight women with hypothalamic amenorrhea: the effects of body composition and nutritional intake. J Clin Endocrinol Metab 1998;83(7):2309–2312. DOI: 10.1210/jcem.83.7.4975
Bouvattier C, Lahlou N, Roger M, et al. Hypoleptinemia is associated with impaired gonadotrophin response to GnRH during late puberty in obese girls, not boys. Eur J Endocrinol 1998;138(6):653–658. DOI: 10.1530/eje.0.1380653
Lappas M, Yee K, Permezel M, et al. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus complicated pregnancies. J Endocrinol 2005;186(3):457–465. DOI: 10.1677/joe.1.06227
Plati E, Kouskouni E, Malamitsi-Puchner A, et al. Vistatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation. Fertil Steril 2010;94(4):1451–1456. DOI: 10.1016/j.fertnstert.2009.04.055
Donato J Jr, Cravo RM, Frazão R, et al. Leptin's effect on puberty in mice is relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 neurons. J Clin Invest 2011;121(1):355–368. DOI: 10.1172/JCI45106
Campos DB, Palin MF, Bordignon V, et al. The beneficial adipokines in reproduction and fertility. Int J Obes (Lond) 2008;32(2):223–231. DOI: 10.1038/sj.ijo.0803719
Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Bio Chem 1995;270(45):26746–26749. DOI: 10.1074/jbc.270.45.26746
Michalakis KG, Segars JH. The role of adiponectin in reproduction: from polycystic ovary syndrome to assisted reproduction. Fertil Steril 2010;94(6):1949–1957. DOI: 10.1016/j.fertnstert.2010.05.010
Lagaly DV, Aad PY, Grado-Ahuir JA, et al. Role of adiponectin in regulating ovarian theca and granulosa cell function. Mol Cell Endocrinol 2008;284(1–2):38–45. DOI: 10.1016/j.mce.2008.01.007
Lecke SB, Morsch DM, Spritzer PM, et al. Leptin and adiponectin in the female life course. Braz J Med Biol Res 2011;44(5):381–387. DOI: 10.1590/S0100-879X2011007500035